Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.950
+0.080 (2.79%)
At close: Jul 20, 2026, 4:00 PM EDT
2.910
-0.040 (-1.36%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $37.64 million as of July 20, 2026. Its market cap has decreased by -12.53% in one year.
Market Cap
37.64M
Enterprise Value
31.37M
1-Year Change
-12.53%
Ranking
Category
Stock Price
$2.95
ChartMarket Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $37.64M, an increase of 24.10%. That is a compound annual growth rate of 3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 37.64M | 11.07% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 40.67M |
| Grace Therapeutics | 40.20M |
| NanoViricides | 39.87M |
| RenovoRx | 39.02M |
| Veru Inc. | 38.20M |
| Nutriband | 37.81M |
| Genenta Science | 36.57M |
| Estrella Immunopharma | 36.15M |